Join
Live feed
·
PRReleasevia Quantisnow
Tempus AI Inc. logo
Recursion Pharmaceuticals Inc. logo

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model

ByQuantisnow·Wall Street's wire, on your screen.
TEM· Tempus AI Inc.RXRX· Recursion Pharmaceuticals Inc.
TechnologyHealth Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TEM (Tempus AI Inc.), RXRX (Recursion Pharmaceuticals Inc.) and more on Quantisnow.